Glycoprotein IX (Platelet) (GP9) (Middle Region) Peptide
Quick Overview for Glycoprotein IX (Platelet) (GP9) (Middle Region) Peptide (ABIN8101779)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- GP9 Peptide - middle region
-
Sequence
- NSLQSVPPGA FDHLPQLQTL DVTQNPWHCD CSLTYLRLWL EDRTPEALLQ
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-GP9 Antibody (ARP61533_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CD42a (GP9) (Glycoprotein IX (Platelet) (GP9))
-
Background
-
Background Information: This gene encodes a small membrane glycoprotein found on the surface of human platelets. It forms a 1-to-1 noncovalent complex with glycoprotein Ib, a platelet surface membrane glycoprotein complex that functions as a receptor for von Willebrand factor. The complete receptor complex includes noncovalent association of the alpha and beta subunits with the protein encoded by this gene and platelet glycoprotein V. Defects in this gene are a cause of Bernard-Soulier syndrome, also known as giant platelet disease. These patients have unusually large platelets and have a clinical bleeding tendency.
Alternative Symbols: CD42a, GPIX
-
Molecular Weight
- 19kDa
-
Gene ID
- 2815
-
NCBI Accession
- NP_000165
-
UniProt
- P14770
Target
-
